153 related articles for article (PubMed ID: 31147959)
1. Screening for natural products that affect Wnt signaling activity.
Ishibashi M
J Nat Med; 2019 Sep; 73(4):697-705. PubMed ID: 31147959
[TBL] [Abstract][Full Text] [Related]
2. Cell-based assay for low- and high-scale screening of the Wnt/β-catenin signaling modulators.
Mazur M; Bujak A; Matloka M; Janowska S; Gunerka P; Bojarski L; Stanczak A; Klejman A; Bednarek A; Lamparska-Przybysz M; Wieczorek M
Anal Biochem; 2015 Apr; 475():56-67. PubMed ID: 25659657
[TBL] [Abstract][Full Text] [Related]
3. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
Usongo M; Li X; Farookhi R
Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
[TBL] [Abstract][Full Text] [Related]
4. RNA-binding motif protein 5 negatively regulates the activity of Wnt/β-catenin signaling in cigarette smoke-induced alveolar epithelial injury.
Hao YQ; Su ZZ; Lv XJ; Li P; Gao P; Wang C; Bai Y; Zhang J
Oncol Rep; 2015 May; 33(5):2438-44. PubMed ID: 25738917
[TBL] [Abstract][Full Text] [Related]
5. Discovery of chemical probes that suppress Wnt/β-catenin signaling through high-throughput screening.
Yamaguchi K; Nagatoishi S; Tsumoto K; Furukawa Y
Cancer Sci; 2020 Mar; 111(3):783-794. PubMed ID: 31912579
[TBL] [Abstract][Full Text] [Related]
6. Bioactive heterocyclic natural products from actinomycetes having effects on cancer-related signaling pathways.
Ishibashi M
Prog Chem Org Nat Prod; 2014; 99():147-98. PubMed ID: 25296439
[No Abstract] [Full Text] [Related]
7. Small molecules from natural products targeting the Wnt/β-catenin pathway as a therapeutic strategy.
Liu D; Chen L; Zhao H; Vaziri ND; Ma SC; Zhao YY
Biomed Pharmacother; 2019 Sep; 117():108990. PubMed ID: 31226638
[TBL] [Abstract][Full Text] [Related]
8. Bioactive Secondary Metabolites with Unique Aromatic and Heterocyclic Structures Obtained from Terrestrial Actinomycetes Species.
Abdelfattah MS; Arai MA; Ishibashi M
Chem Pharm Bull (Tokyo); 2016 Jul; 64(7):668-75. PubMed ID: 26936155
[TBL] [Abstract][Full Text] [Related]
9. Polycyclic aromatic hydrocarbons and dibutyl phthalate disrupt dorsal-ventral axis determination via the Wnt/β-catenin signaling pathway in zebrafish embryos.
Fairbairn EA; Bonthius J; Cherr GN
Aquat Toxicol; 2012 Nov; 124-125():188-96. PubMed ID: 22975441
[TBL] [Abstract][Full Text] [Related]
10. Targeting the wingless signaling pathway with natural compounds as chemopreventive or chemotherapeutic agents.
Teiten MH; Gaascht F; Dicato M; Diederich M
Curr Pharm Biotechnol; 2012 Jan; 13(1):245-54. PubMed ID: 21466435
[TBL] [Abstract][Full Text] [Related]
11. The Wnt Transcriptional Switch: TLE Removal or Inactivation?
Ramakrishnan AB; Sinha A; Fan VB; Cadigan KM
Bioessays; 2018 Feb; 40(2):. PubMed ID: 29250807
[TBL] [Abstract][Full Text] [Related]
12. γ-Tocotrienol inhibits cell viability through suppression of β-catenin/Tcf signaling in human colon carcinoma HT-29 cells.
Xu W; Du M; Zhao Y; Wang Q; Sun W; Chen B
J Nutr Biochem; 2012 Jul; 23(7):800-7. PubMed ID: 21852086
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of β-catenin signaling.
Lee MA; Park HJ; Chung HJ; Kim WK; Lee SK
J Nat Prod; 2013 Jul; 76(7):1278-84. PubMed ID: 23855266
[TBL] [Abstract][Full Text] [Related]
14. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
Dieudonné FX; Marion A; Marie PJ; Modrowski D
J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
[TBL] [Abstract][Full Text] [Related]
15. Advances in targeting the WNT/β-catenin signaling pathway in cancer.
Chatterjee A; Paul S; Bisht B; Bhattacharya S; Sivasubramaniam S; Paul MK
Drug Discov Today; 2022 Jan; 27(1):82-101. PubMed ID: 34252612
[TBL] [Abstract][Full Text] [Related]
16. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
17. Sesterterpenoid and Steroid Metabolites from a Deep-Water Alaska Sponge Inhibit Wnt/β-Catenin Signaling in Colon Cancer Cells.
Park HB; Tuan NQ; Oh J; Son Y; Hamann MT; Stone R; Kelly M; Oh S; Na M
Mar Drugs; 2018 Aug; 16(9):. PubMed ID: 30150508
[TBL] [Abstract][Full Text] [Related]
18. The recent update and advancements of natural products in targeting the Wnt/β-Catenin pathway for cancer prevention and therapeutics.
Saikia L; Gogoi B; Sen S; Tonk RK; Kumar D; Dutta PP
Med Oncol; 2024 May; 41(7):164. PubMed ID: 38816663
[TBL] [Abstract][Full Text] [Related]
19.
Zhang QH; Hu QX; Xie D; Chang B; Miao HG; Wang YG; Liu DZ; Li XD
Integr Cancer Ther; 2019; 18():1534735419890917. PubMed ID: 31855073
[No Abstract] [Full Text] [Related]
20. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy.
Dzobo K; Thomford NE; Senthebane DA
OMICS; 2019 Nov; 23(11):517-538. PubMed ID: 31613700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
